[
	{
		"id":"info",
		"type":"internal",
		"title":"Information",
		"keyboardShortcut":"",
		"template":"templates/info_pop",
		"menuId":"",
		"content":{
			"text":"Info text"
		}
	},
	{
		"id":"9B4-example-1",
		"type":"internal",
		"title":"Example 1",
		"keyboardShortcut":"",
		"template":"templates/example_pop_lists",
		"menuId":"",
		"content":{
			"image": "9b4_example_01.png",
			"lists":[
				{
					"title": "Recent Accomplishments:",
					"items": [
						{"text":"Met timeless for first patient for amendment 3 after enrollment had been on hold."},
						{"text":"Caugh up on SDV backlog at 2 of 3 sites"}
					]
				},
				{
					"title": "Upcoming Deliverables:",
					"items": [
						{"text":"SDV backlog caught up at MDACC  and site data entry to be caught"},
						{"text":"Approval of amendment 3 and addition of 2 new sites (IRB approval at OKC, SIV scheduled for 20 Jan 2014, pending IRB approval at Karmanos)"},
						{"text":"SIV’s for two new sites"}
					]
				},
				{
					"title": "Key Risks/Challenges:",
					"items": [
						{"text":"Amendment 3 dosing is chaning from every 3 weeks to weekly dosing (essentially new protocol)"},
						{"text":"Increased time for site training during RMV. Backlog of data entry and SDV at one site (resolution plan is in place)•"}
					]
				}
			]
		}
	},
	{
		"id":"9B4-example-2",
		"type":"internal",
		"title":"Example 2",
		"keyboardShortcut":"",
		"template":"templates/example_pop_text",
		"menuId":"",
		"content":{
			"image": "9b4_example_02.png"
		}
	},
	{
		"id":"9B4-example-3",
		"type":"Example 3",
		"title":"Example 3",
		"keyboardShortcut":"",
		"template":"templates/example_pop_text",
		"menuId":"",
		"content":{
			"image": "9b4_example_03.png"
		}
	},
	{
		"id":"9B5-example-1",
		"type":"internal",
		"title":"Example 1",
		"keyboardShortcut":"",
		"template":"templates/example_pop_text",
		"menuId":"",
		"content":{
			"text":"If the blind is broken, it would trigger an action by the Bayer team to review why the subject’s blind was broken.",
			"image": "9b5_example_01.png"
		}
	},
	{
		"id":"9B5-example-2",
		"type":"internal",
		"title":"Example 2",
		"keyboardShortcut":"",
		"template":"templates/example_pop_text",
		"menuId":"",
		"content":{
			"text":"Another example is if data backlog metrics continue to be above the established threshold for more than 2 reporting cycles, Bayer could request weekly updates on Covance action plans.",
			"image": "9b5_example_02.png"
		}
	}

]

